The report will be delivered in 2-3 business days.
Banner

Hydroxychloroquine Global Market Report 2021 - By Drug Activity (Anti-Malarial Drug, Anti-Rheumatic Drug, Lupus Suppressant Drug, Anti COVID-19 Drug), By Formulation (Tablets, Injection), By Application (Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Speciality Drug Stores, Retail Pharmacy), COVID-19 Implications And Growth

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : March 2021 | SKU CODE : 7558 | Format :


The hydroxychloroquine market consists of revenue generated by establishments through the sales of hydroxychloroquine drugs. It is an antimalarial drug used for the treatment of malaria, systemic lupus erythematosus (SLE), and rheumatoid arthritis. Hydroxychloroquine is used in combination with antibiotic azithromycin as a potential treatment for COVID-19.

The hydroxychloroquine market covered in this report is segmented by drug activity into anti-malarial, anti-rheumatic, lupus suppressant, anti COVID-19, others. The hydroxychloroquine market is also segmented by formulation into tablets, injection; by application into malaria, rheumatoid arthritis, lupus erythematosus, COVID-19, others; by distribution channel into hospital pharmacy, online pharmacy, specialty drug stores, retail pharmacy.

The global hydroxychloroquine market is expected to grow from $0.93 billion in 2020 to $1.02 billion in 2021 at a compound annual growth rate (CAGR) of 9.7%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The hydroxychloroquine market is expected to reach $1.51 billion in 2025 at a CAGR of 10%.

The increasing number of coronavirus cases has increased the demand for hydroxychloroquine in 2020. The demand for hydroxychloroquine is growing attributing to its use in the treatment of COVID-19 patients and in the ongoing clinical trials. The US Food and Drug Administration has authorized emergency use of hydroxychloroquine for the treatment of COVID-19 patients in the hospital or enrolled by clinical trials. According to the World Health Organization (WHO), there were more than 10 million confirmed cases of COVID-19, including more than 500,000 deaths reported as of 3rd July 2020, globally. USA, Brazil, Russia, UK, India and Spain are the countries most affected by the virus. Therefore, the continuous increase in coronavirus cases across the globe is surging the demand for hydroxychloroquine, generating higher revenues for the market during the period.

 

Side effects associated with the use of hydroxychloroquine drugs is predicted to limit market growth. The side effects associated with the use of hydroxychloroquine for the treatment of COVID patients include serious and potentially life-threatening heart rhythm problems. In April 2020, the US Food and Drug Administration warned against the side-effects of hydroxychloroquine and issued a safety communication regarding the side-effects of using the drug for COVID-19 outside of the hospital settings or clinical trials. Moreover, the World Health Organization (WHO) had suspended the clinical trials of hydroxychloroquine over safety concerns on the 25th of May 2020. However, the trials have been resumed by WHO on the 3rd of June 2020 after reviewing safety concerns. Nonetheless, the potential side effects restrict the use of hydroxychloroquine outside the hospital and clinical settings, thereby hindering the growth of the hydroxychloroquine market going forward.

 

Major players operating in the market are undertaking various strategic initiatives such as increasing production capacity and the expansion of manufacturing plants to meet the augmented global demand. For instance, in April 2020, Zydus Cadila announced that the company has ramped up its production capacity by 10 times for the production of hydroxychloroquine post the COVID-19 outbreak. Moreover, other manufacturers including IPCA Laboratories increased their monthly hydroxychloroquine production capacity five to six times during May 2020. Thus, the ramp-up of production capacities by major companies is a major trend shaping the hydroxychloroquine market.

 

In July 2019, Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, off-patent branded and generic establishment medicines business of Pfizer for an undisclosed amount to creating a new global pharmaceutical company. The new company is expected to transform and accelerate both companies’ ability to serve patients and expand their capabilities across more than 165 markets. Mylan N.V. was founded in 1961 and is a global generic and specialty pharmaceuticals company.

 

Major players in the hydroxychloroquine market are Bayer AG, Dr. Reddy's Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Wallace Pharma, Teva, Mylan, Novartis, and Intas Pharmaceuticals.

The regions covered in the hydroxychloroquine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hydroxychloroquine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global hydroxychloroquine market is segmented -

1) By Drug Activity: Anti-Malarial Drug, Anti-Rheumatic Drug, Lupus Suppressant Drug, Anti COVID-19 Drug, Others

2) By Formulation: Tablets, Injection

3) By Application: Malaria, Rheumatoid Arthritis, Lupus Erythematosus, COVID-19, Others

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Speciality Drug Stores, Retail Pharmacy

    Table Of Contents

    1. Executive Summary

    2. Hydroxychloroquine Market Characteristics

    3. Hydroxychloroquine Market Trends And Strategies

    4. Impact Of COVID-19 On Hydroxychloroquine

    5. Hydroxychloroquine Market Size And Growth

    5.1. Global Hydroxychloroquine Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Hydroxychloroquine Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Hydroxychloroquine Market Segmentation

    6.1. Global Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Anti-Malarial Drug

    Anti-Rheumatic Drug

    Lupus Suppressant Drug

    Anti COVID-19 Drug

    Others

    6.2. Global Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Tablets

    Injection

    6.3. Global Hydroxychloroquine Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Malaria

    Rheumatoid arthritis

    Lupus Erythematosus

    COVID-19

    Others

    6.4. Global Hydroxychloroquine Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospital pharmacy

    Online pharmacy

    Speciality drug stores

    Retail pharmacy

    7. Hydroxychloroquine Market Regional And Country Analysis

    7.1. Global Hydroxychloroquine Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Hydroxychloroquine Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Hydroxychloroquine Market

    8.1. Asia-Pacific Hydroxychloroquine Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Hydroxychloroquine Market

    9.1. China Hydroxychloroquine Market Overview

    9.2. China Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Hydroxychloroquine Market

    10.1. India Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Hydroxychloroquine Market

    11.1. Japan Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Hydroxychloroquine Market

    12.1. Australia Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Hydroxychloroquine Market

    13.1. Indonesia Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Hydroxychloroquine Market

    14.1. South Korea Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Hydroxychloroquine Market

    15.1. Western Europe Hydroxychloroquine Market Overview

    15.2. Western Europe Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Hydroxychloroquine Market

    16.1. UK Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Hydroxychloroquine Market

    17.1. Germany Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Hydroxychloroquine Market

    18.4. France Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Hydroxychloroquine Market

    19.1. Eastern Europe Hydroxychloroquine Market Overview

    19.2. Eastern Europe Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Hydroxychloroquine Market

    20.1. Russia Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Hydroxychloroquine Market

    21.1. North America Hydroxychloroquine Market Overview

    21.2. North America Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Hydroxychloroquine Market

    22.1. USA Hydroxychloroquine Market Overview

    22.2. USA Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Hydroxychloroquine Market

    23.1. South America Hydroxychloroquine Market Overview

    23.2. South America Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Hydroxychloroquine Market

    24.1. Brazil Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Hydroxychloroquine Market

    25.1. Middle East Hydroxychloroquine Market Overview

    25.2. Middle East Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Hydroxychloroquine Market

    26.1. Africa Hydroxychloroquine Market Overview

    26.2. Africa Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Hydroxychloroquine Market Competitive Landscape And Company Profiles

    27.1. Hydroxychloroquine Market Competitive Landscape

    27.2. Hydroxychloroquine Market Company Profiles

    27.2.1. Bayer AG

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Dr. Reddy's Laboratories

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Zydus Cadila

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Ipca Laboratories Ltd.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Wallace Pharma

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Hydroxychloroquine Pipeline Analysis

    29. Key Mergers And Acquisitions In The Hydroxychloroquine Market

    30. Hydroxychloroquine Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Hydroxychloroquine Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Hydroxychloroquine Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Hydroxychloroquine Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Global Hydroxychloroquine Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: China, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: China, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: India, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: India, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Japan, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Japan, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Australia, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Australia, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Indonesia, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Indonesia, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: South Korea, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: South Korea, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Western Europe, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: Western Europe, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: UK, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: UK, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Germany, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: Germany, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: France, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: France, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Eastern Europe, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Russia, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: Russia, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: North America, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: North America, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: USA, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: USA, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: South America, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: South America, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: Brazil, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Brazil, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Middle East, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Middle East, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Africa, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Africa, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 47: Bayer AG Financial Performance
  • Table 48: Dr. Reddy's Laboratories Financial Performance
  • Table 49: Zydus Cadila Financial Performance
  • Table 50: Ipca Laboratories Ltd. Financial Performance
  • Table 51: Wallace Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Hydroxychloroquine Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Hydroxychloroquine Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Hydroxychloroquine Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Global Hydroxychloroquine Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: China, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: China, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: India, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: India, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Japan, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Japan, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Australia, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Australia, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Indonesia, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: South Korea, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: South Korea, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: Western Europe, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: UK, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: UK, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Germany, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: Germany, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: France, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: France, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Eastern Europe, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Russia, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: Russia, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: North America, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: North America, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: USA, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: USA, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: South America, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: South America, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: Brazil, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Brazil, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Middle East, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Middle East, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Africa, Hydroxychloroquine Market, Segmentation By Drug Activity, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Africa, Hydroxychloroquine Market, Segmentation By Formulation, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 47: Bayer AG Financial Performance
  • Figure 48: Dr. Reddy's Laboratories Financial Performance
  • Figure 49: Zydus Cadila Financial Performance
  • Figure 50: Ipca Laboratories Ltd. Financial Performance
  • Figure 51: Wallace Pharma Financial Performance
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Biosimilar Monoclonal Antibodies Global Market Report 2021 - By Type (Synthetic Chemicals, Biopharmaceuticals), By Application (Chronic & Autoimmune Diseases, Oncology), By Compound (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab), COVID-19 Growth And Change
View Report
Biosimilar Therapeutic Peptides Global Market Report 2021 - By Route Of Administration (Parenteral Route, Transdermal Route), By Application (Cancer, Cardiovascular, Central Nervous Systems, Metabolic Disorders, Infection, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders), By Type (Innovative, Generic), COVID-19 Growth And Change
View Report
Rituximab Biosimilars Global Market Report 2021 - By Application (Non-Hodgkin's Lymphoma, Chronic Lymhocytic Leukemia, Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Direct Distribution Channels), By Route Of Administration (Subcutaneous, Intravenous, Molecular Type), COVID-19 Growth And Change
View Report
Biosimilar Hormones Global Market Report 2021 - By Type (Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars), By Application (Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics), By Distribution Channel (Hospital And Retail Pharmacy, Online Pharmacy/epharmacy, Speciality Clinics), COVID-19 Growth And Change
View Report
Biosimilar Lymphocyte Modulator Global Market Report 2021 - By Drug (Campath-1H, Natalizumab Biosimilar, Efalizumab - A1089-Anti-CD11a Bisoimilar, Anti-CD38 Daratumumab Biosimilar, Anti-CS1 Elotuzumab Bisoimilar), By Disease (Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Psoriasis), COVID-19 Growth And Change
View Report
Biosimilars Global Market Report 2021 - By Product (Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins), By Types (Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor), By Application (Oncology, Chronic And Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases), COVID-19 Growth And Change
View Report
Filgrastim Biosimilars Market - By Application (Oncology, Chronic and Autoimmune Diseases, Blood disorders, Growth hormone deficiency), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), And By Region, Opportunities And Strategies – Global Filgrastim Biosimilars Market Forecast To 2030
View Report
Pegfilgrastim Biosimilars Market - By Application (Chemotherapy Induced Neutropenia, Transplantation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Mail Order/Online Pharmacies), And By Region, Opportunities And Strategies – Global Pegfilgrastim Biosimilars Market Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)